60 DEGREES PHARMACEUTICALS, INC.: INTRACOASTAL CAPITAL, LLC amends Schedule 13G stake filing

Intracoastal Capital, LLC amended its Schedule 13G stake filing for 60 Degrees Pharmaceuticals, Inc., disclosing the change to the SEC under accession number 0001213900-26-118167. The filing updates the investor's previously reported position in the small-cap pharmaceutical company, though the amended document did not specify a revised share count or percentage in the headline disclosure. Schedule 13G amendments are typically watched for signals about passive investors' changing exposure to a company, and the update follows the standard annual or material-change reporting cadence for qualifying institutional holders. Investors will look to the full filing for the exact share total and ownership percentage, and to any subsequent 13D or Form 4 activity for signs of a more active stance in the stock.